We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adherence Improvement in Glaucoma Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00603005
First Posted: January 28, 2008
Last Update Posted: February 24, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Alcon Research
Information provided by:
Maastricht University Medical Center
January 15, 2008
January 28, 2008
February 24, 2010
October 2007
October 2009   (Final data collection date for primary outcome measure)
Intraocular pressure [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT00603005 on ClinicalTrials.gov Archive Site
Information with regard to the use of eye drops from data generated by the TravAlert dosing system [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Adherence Improvement in Glaucoma Patients
Adherence Improvement in Glaucoma Patients
The purpose of this study is to study the effect on intraocular pressure in glaucoma patients using the TravAlert dosing aid with or without the Eyot drop guider and with or without additional patient education.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Care Provider)
Primary Purpose: Supportive Care
Glaucoma
Device: Use of TravAlert dosing aid with or without drop guider
Each patient will use a dosing aid and/or drop guider for 6 months
  • Experimental: 1
    Intervention: Device: Use of TravAlert dosing aid with or without drop guider
  • Experimental: 2
    Intervention: Device: Use of TravAlert dosing aid with or without drop guider
  • Experimental: 3
    Intervention: Device: Use of TravAlert dosing aid with or without drop guider
  • Experimental: 4
    Intervention: Device: Use of TravAlert dosing aid with or without drop guider
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
802
January 2010
October 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis glaucoma or ocular hypertension
  • Treatment with travoprost or travoprost/timolol

Exclusion Criteria:

  • High risk of side effects expected from travoprost or travoprost/timolol
  • Absolute inability to administer eye drops
  • Difficulty in reading or speaking Dutch
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
 
NCT00603005
MEC 07-1-015
CTCM-071015
Yes
Not Provided
Not Provided
Dr. H.J.M. Beckers, MD, phD, Department of Ophthalmology, University Hospital Maastricht
Maastricht University Medical Center
Alcon Research
Principal Investigator: Helena J Beckers, MD/phD Maastricht University Medical Center
Maastricht University Medical Center
February 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP